NEWS RELEASE: Zeus Launches PFX™ Platform and Introduces PFX Flex™ Sub-Lite-Wall™, Advancing the Future of Catheter Innovation
Polymer platform sets a new standard for catheter design with PTFE-like performance and expanded material flexibility
[Image courtesy of Zeus]
Orangeburg, S.C. – Zeus, a global leader in advanced polymer solutions, today announced the launch of PFX™, a breakthrough platform designed to advance catheter innovation with a focus on performance, design flexibility, and sustainability.
Zeus also introduced PFX Flex™ Sub-Lite-Wall™, the first product in the PFX portfolio and a next-generation catheter liner engineered as an alternative to film-cast PTFE.
For decades, PTFE has set the standard in catheter performance. As device designs continue to evolve, OEMs are seeking materials that maintain trusted performance while enabling greater flexibility, scalability, and long-term confidence. The PFX platform represents a new chapter in catheter innovation, bringing together a portfolio of non-fluorinated polymer solutions that match the performance characteristics R&D engineers rely on, while opening new possibilities in catheter design and manufacturing.
“PFX reflects how we think about innovation at Zeus,” said Paddy O’Brien, Chief Executive Officer of Zeus. “It’s about anticipating where our customers are going and investing ahead of that curve. With PFX, we’re extending our leadership in polymer science to help OEMs design what’s next with confidence.”
PFX Flex™ Sub-Lite-Wall™: The First Product in the PFX Portfolio
The first product introduced under the PFX platform, PFX Flex Sub-Lite-Wall, is engineered to deliver PTFE-like lubricity, flexibility, and enhanced bond strength through the material itself, without additives or coatings. The material bonds directly to thermoplastics without chemical etching and is compatible with sterilization methods beyond EtO, including gamma and e-beam.
PFX Flex Sub-Lite-Wall liners are available in inner diameters ranging from 0.013″ to 0.387″, expanding design freedom across a wide range of catheter platforms and enabling applications that have traditionally relied on film-cast materials.
“For a long time, PTFE was viewed as irreplaceable in high-performance catheter applications,” said Suresh Sainath, Chief Technology Officer at Zeus. “The PFX platform challenges that assumption. It delivers performance parity where it matters most, while enabling new levels of design flexibility. This is a meaningful advancement in catheter material science.”
A Strategic Platform Built for What’s Next
Beyond individual product performance, PFX is designed as a scalable platform that supports a growing portfolio of polymer solutions tailored to evolving catheter requirements. Additional PFX products, including advanced catheter liners and heat-shrink solutions, are already in development with new introductions planned later this year.
In addition to performance and design flexibility, the PFX platform was developed with sustainability in mind, giving OEMs a material foundation that aligns with long-term environmental and supply chain priorities. PFX supports continuity and confidence over time, without forcing trade-offs in performance or reliability.
“Our customers want to move forward without taking on unnecessary risk,” said Jim O’Connell, Chief Commercial Officer at Zeus. “PFX gives them a strong foundation to engage early, explore new designs, and gain a first-mover advantage as catheter technology continues to evolve, all while aligning with longer-term sustainability priorities.”
MD&M West Showcase
Zeus will showcase the PFX platform and PFX Flex™ Sub-Lite-Wall™ at MD&M West, where attendees can connect with Zeus experts to learn more about how PFX supports next-gen catheter design. Visit Zeus at Booth #3001.
For more information, visit www.zeusinc.com/PFX/Flex
About Zeus
Zeus, headquartered in Orangeburg, South Carolina, is the world’s leading polymer extrusion and catheter design manufacturer. More than 60 years of experience in medical, aerospace, energy, automotive, fiber optics, and more allows Zeus to achieve its mission to provide solutions, enable innovation, and enhance lives. The company employs over 2,200 people worldwide with facilities in Aiken, Columbia, Gaston, Orangeburg, St. Matthews, South Carolina; Branchburg, New Jersey; Chattanooga, Tennessee; San Jose, California; Arden Hills, Minnesota; Guangzhou, China; and Letterkenny, Ireland.
For more information, visit www.zeusinc.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
